<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cassedy A</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>Arthritis Foundation</funding><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>Rheumatology Research Foundation</funding><funding>Childhood Arthritis and Rheumatology Research Alliance</funding><funding>Knights Templar Eye Foundation</funding><funding>NIAMS NIH HHS</funding><pagination>355-363</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12498490</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>74(3)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q.&lt;h4>Methods&lt;/h4>Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations,</pubmed_abstract><journal>Arthritis care &amp; research</journal><pubmed_title>Assessing the Validity and Reliability of the Effects of Youngsters' Eyesight on Quality of Life Questionnaire Among Children With Uveitis.</pubmed_title><pmcid>PMC12498490</pmcid><funding_grant_id>P30 AR076316</funding_grant_id><funding_grant_id>R01‐EY‐030521</funding_grant_id><funding_grant_id>K23 EY021760</funding_grant_id><funding_grant_id>L40 EY019856</funding_grant_id><funding_grant_id>K23‐EY‐021760</funding_grant_id><funding_grant_id>UL1‐TR‐000077</funding_grant_id><pubmed_authors>Engelhard G</pubmed_authors><pubmed_authors>Holland GN</pubmed_authors><pubmed_authors>Walker AA</pubmed_authors><pubmed_authors>Lipscomb J</pubmed_authors><pubmed_authors>McDonald J</pubmed_authors><pubmed_authors>Prahalad S</pubmed_authors><pubmed_authors>Mwase N</pubmed_authors><pubmed_authors>Drews-Botsch C</pubmed_authors><pubmed_authors>Hennard T</pubmed_authors><pubmed_authors>McCracken C</pubmed_authors><pubmed_authors>Andringa J</pubmed_authors><pubmed_authors>Lambert SR</pubmed_authors><pubmed_authors>Cooper AM</pubmed_authors><pubmed_authors>Stahl E</pubmed_authors><pubmed_authors>Angeles-Han ST</pubmed_authors><pubmed_authors>Utz VM</pubmed_authors><pubmed_authors>Yeh S</pubmed_authors><pubmed_authors>Cassedy A</pubmed_authors><pubmed_authors>McCurdy DK</pubmed_authors><pubmed_authors>Altaye M</pubmed_authors><pubmed_authors>Jenkins K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessing the Validity and Reliability of the Effects of Youngsters' Eyesight on Quality of Life Questionnaire Among Children With Uveitis.</name><description>&lt;h4>Objective&lt;/h4>The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) questionnaire measures vision-related functioning (VRF) and vision-related quality of life (VRQoL) in children with uveitis. Our aim was to revise the alpha version of the EYE-Q to refine VRF and VRQoL subscales and to assess the validity of the EYE-Q.&lt;h4>Methods&lt;/h4>Children with juvenile idiopathic arthritis (JIA), JIA-associated uveitis, and other noninfectious uveitis were enrolled. Patients and parents completed the EYE-Q, Pediatric Quality of Life Inventory (overall quality of life), and Childhood Health Assessment Questionnaire (physical functioning). The development site completed the alpha version of the EYE-Q, and the composite sites completed the beta version. We compared item-subscale correlations,</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-06-04T04:49:54.255Z</modification><creation>2026-05-05T03:12:42.178Z</creation></dates><accession>S-EPMC12498490</accession><cross_references><pubmed>33085849</pubmed><doi>10.1002/acr.24491</doi></cross_references></HashMap>